CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Conditions: HIV-1-infection; Pregnancy; Postpartum Interventions: Drug: CAB LA 600mg; Drug: RPV LA 900mg; Drug: CAB LA 400mg; Drug: RPV LA 600mg Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials